Access cutting-edge soft tissue sarcoma treatment through this clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Access soft tissue sarcoma specialists in Memphis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related soft tissue sarcoma treatment provided free
The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free survival for intermediate-risk patients treated with ifosfamide, doxorubicin, pazopanib, surgery, and maintenance pazopanib, with or without RT. * To characterize the pharmacokinetics of pazopanib and doxorubicin in combination with ifosfamide in intermediate-risk participants, to assess potential covariates to explain the inter- and intra-indivi
Sponsor: St. Jude Children's Research Hospital
Check if you qualify for this soft tissue sarcoma clinical trial in Memphis, TN
If you're searching for soft tissue sarcoma treatment options in Memphis, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced soft tissue sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.